Antifibrillatory effects of clofilium in the rabbit isolated heart
Open Access
- 1 September 1994
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 113 (1) , 209-215
- https://doi.org/10.1111/j.1476-5381.1994.tb16195.x
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Effects of WAY-123,398, a New Class III Antiarrhythmic Agent, on Cardiac Refractoriness and Ventricular Fibrillation Threshold in Anesthetized Dogs: A Comparison with UK-68798, E-4031, and dl-SotalolJournal of Cardiovascular Pharmacology, 1992
- Dofetilide, A Novel Class III Antiarrhythmic AgentJournal of Cardiovascular Pharmacology, 1992
- Antiarrhythmic and Electrophysiologic Actions of CK-357 and Sematilide in a Conscious Canine Model of Sudden Coronary DeathJournal of Cardiovascular Pharmacology, 1990
- Profibrillatory Actions of Pinacidil in a Conscious Canine Model of Sudden Coronary DeathJournal of Cardiovascular Pharmacology, 1990
- Effect of the combination of diltiazem and atenolol on exercise-induced regional myocardial ischemia in conscious dogs.Circulation, 1985
- Ventricular fibrillation in a conscious canine preparation of sudden coronary death--prevention by short- and long-term amiodarone administration.Circulation, 1983
- Prolongation of cardiac refractory times in man by clofilium phosphate, a new antiarrhythmic agentAmerican Heart Journal, 1983
- Clofilium1--a new antifibrillatory agent that selectively increases cellular refractorinessLife Sciences, 1979
- Chemical ventricular defibrillation of the human heart with bretylium tosylateThe American Journal of Cardiology, 1973
- Treatment of ventricular fibrillation and other acute arrhythmias with bretylium tosylateThe American Journal of Cardiology, 1968